ELESTAT Trademark

Trademark Overview

On Monday, September 15, 2003, a trademark application was filed for ELESTAT with the United States Patent and Trademark Office. The USPTO has given the ELESTAT trademark a serial number of 78300353. The federal status of this trademark filing is REGISTERED AND RENEWED as of Friday, July 18, 2025. This trademark is owned by ALLERGAN, INC.. The ELESTAT trademark is filed in the Pharmaceutical Products category with the following description:

Topical ophthalmic anti-allergy and anti-inflammatory preparations for the treatment of ocular conditions
elestat

General Information

Serial Number78300353
Word MarkELESTAT
Filing DateMonday, September 15, 2003
Status800 - REGISTERED AND RENEWED
Status DateFriday, July 18, 2025
Registration Number2937034
Registration DateTuesday, March 29, 2005
Mark Drawing1 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 27, 2004

Trademark Statements

Goods and ServicesTopical ophthalmic anti-allergy and anti-inflammatory preparations for the treatment of ocular conditions

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 1, 2003
Primary Code005
First Use Anywhere DateWednesday, September 10, 2003
First Use In Commerce DateMonday, February 2, 2004

Trademark Owner History

Party NameBOEHRINGER INGELHEIM INTERNATIONAL GMBH
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressINGELHEIM 55216
DE
Party NameALLERGAN, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressIRVINE, CA 92612
Party NameALLERGAN, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIRVINE, CA 92612
Party NameALLERGAN, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIRVINE, CA 92612

Trademark Events

Event DateEvent Description
Tuesday, October 7, 2003PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Tuesday, October 7, 2003TEAS VOLUNTARY AMENDMENT RECEIVED
Tuesday, October 7, 2003CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 23, 2004ASSIGNED TO EXAMINER
Tuesday, February 24, 2004ASSIGNED TO EXAMINER
Thursday, February 26, 2004EXAMINERS AMENDMENT E-MAILED
Wednesday, March 3, 2004APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 7, 2004NOTICE OF PUBLICATION
Tuesday, April 27, 2004PUBLISHED FOR OPPOSITION
Tuesday, July 20, 2004NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 3, 2004TEAS STATEMENT OF USE RECEIVED
Tuesday, August 3, 2004USE AMENDMENT FILED
Thursday, August 19, 2004STATEMENT OF USE PROCESSING COMPLETE
Saturday, March 28, 2015REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Friday, September 10, 2004ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, September 21, 2004ASSIGNED TO LIE
Friday, September 24, 2004LAW OFFICE REGISTRATION REVIEW COMPLETED
Tuesday, March 29, 2005REGISTERED-PRINCIPAL REGISTER
Friday, May 6, 2011TEAS SECTION 8 & 15 RECEIVED
Sunday, June 5, 2011CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sunday, June 5, 2011REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, March 13, 2015TEAS SECTION 8 & 9 RECEIVED
Saturday, March 28, 2015CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Saturday, March 28, 2015REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Monday, July 14, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, July 18, 2025REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
Friday, July 18, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Friday, July 18, 2025REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Saturday, March 28, 2015NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Friday, March 29, 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, February 12, 2025TEAS SECTION 8 & 9 RECEIVED

Related Keywords

elestat anti treatment ocular preparations conditions inflammatory ophthalmic allergy topical